The role of IL-13 and NK T cells in experimental and human ulcerative colitis
- PMID: 19079225
- PMCID: PMC3673706
- DOI: 10.1038/mi.2008.40
The role of IL-13 and NK T cells in experimental and human ulcerative colitis
Abstract
Recent studies that have evaluated the immunologic factors that mediate the development of the two forms of inflammatory bowel disease, namely Crohn's disease and ulcerative colitis (UC), have suggested that these diseases are because of disparate immune responses. Although Crohn's disease has been characterized as a dysregulation of the T helper (Th)1/Th17 pathways more recent evidence has emerged that UC pathogenesis is associated with a nonclassical NK (natural killer) T cell producing an atypical Th2 (interleukin (IL)-13) response. In the following review the insights gained from both animal models and human studies as to the function that IL-13 and NK T cells have in the pathogenesis of UC will be discussed.
Figures
References
-
- Fuss IJ, Neurath M, Boirivant M, Klein JS, et al. Disparate CD4+ lamina propria (LP) lymphokines secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996;153(3):1261–1270. - PubMed
-
- Heller F, Fuss IJ, Niewenhuis EE, Blumberg RS, Strober W. Oxazalone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002;17(5):629–638. - PubMed
-
- Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002;2(8):557–568. - PubMed
-
- Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004;22:817–890. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
